Viking Therapeutics Stock Price Soars on Positive Weight Loss Drug Data

Weight-loss drugs like Ozempic have fueled a rally in pharmaceutical stocks in 2024, as investors eye the strong adoption of GLP-1 drugs.

Related Keywords

California ,United States ,America ,Americans ,Eli Lilly ,Goldman Sachs ,Terms Of Service ,Novo Nordisk ,Viking Therapeutic ,Markets ,Mi Exclusive ,Viking Therapeutics ,Weight Loss Drugs ,Glp 1 ,Hares ,Stock Market ,Obesity ,Clinical Trial ,